Commercial insight into the pharma and biotech sector.
Solutions for Forecasting
As forecasting evolves to support strategic planning at the corporate level, benchmarking against credible external forecasts for company and sector performance and valuations is essential. EvaluatePharma’s forecasts are continuously updated providing a unique benchmark for your own forecasts against the consensus of the equity research community.
- Benchmark internal forecasts against the consensus from leading equity research analysts to support your strategic planning
- Build credible models for future sector performance of products, pipelines and entire companies with our interactive NPV Analyzer
- Model potential impact of industry events on product & company valuation with NPV Analyzer including patent extension, litigation & clinical trials
- Access in-depth full financial models linked to business segment, product forecasts & over 3500 global product NPVs
- Rely with confidence on rigorous & consistent methodology with standardized, consistent reporting across geographies & business segments
- Get unique insight into forecast changes with our unique catalogue of Archived Forecasts with 100,000 worldwide product sales forecasts from January 2003
Discover more Solutions for Forecasting